Shwetal V Mehta

Title: Shwetal V Mehta: Innovator in Genetic Research

Introduction

Shwetal V Mehta is a prominent inventor based in Chandler, AZ (US). She has made significant contributions to the field of genetic research, particularly in understanding the vulnerabilities associated with cancer treatment. With a total of 2 patents, her work focuses on the Base Excision Repair (BER) pathway, which plays a crucial role in DNA repair.

Latest Patents

One of her latest patents is titled "Genetic signature of vulnerability to inhibitors of base excision repair (BER) in cancer." This invention relates to the identification of genetic signatures and expression profiles that are integral to the BER pathway. In one embodiment, the invention provides a method for determining the responsiveness of treatment by BER inhibitors for malignant glioma. This is achieved by assessing the presence of a low level of expression of Apex 1, a low level of expression of Apex 2, and a high level of expression of MPG.

Career Highlights

Throughout her career, Shwetal has worked with notable organizations such as Dignity Health and the Translational Genomics Research Institute. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of her notable coworkers include Michael E Berens and Harshil Dineshkumar Dhruv. Their collaborative efforts have further advanced the understanding of genetic vulnerabilities in cancer treatment.

Conclusion

Shwetal V Mehta's innovative work in genetic research highlights her commitment to improving cancer treatment through scientific discovery. Her contributions to the BER pathway and her collaborations with esteemed colleagues underscore her impact in the field.